This years AGBT has again been a full program from dawn to dusk (or later). This year my favourite session has been Fridays Genomic Technologies Development session. It was the most technologically focused session with five great talks and one that I thought was outstanding.Patrick […]
There were three great talks in the opening session of AGBT yesterday but before we kicked off Eric Green reminded everyone in the audience about the “opt-in” policy on blogging and tweeting (and any other kind of media). If someone opts out then we can’t […]
I had a long and tiring trip to Miami yesterday with two hours of immigration and security. I wok up at 4am thanks to jet-lag and decided to drive over to AGBT at Marco Island via I41 through the everglades and Big Cyprus national park. […]
AGBT is not all hard work; there’s blogs to be written, Tweets to tweet and drinks to be drunk. Coverage from Bloggers and Tweeters is usually pretty good and makes up a little for not actually getting there, I know as I missed last year […]
Last month I posted a logical puzzle to see if people knew how much different next-gen sequencing applications cost? The repsonses have been varied!Now Illumina have very kindly donated a MiSeq run and 250 iCredits as the prize for a festive competition. You can win […]
It’s amazing what is being done with DNA sequencing. Cancer genetics and personalised medicine make headlines, consumer genomics has been in the news and Genomics England are going to sequence 100,000 NHS patients. But all that glitters is not gold! I’m not sure everyone will […]
Updated after reading Dale Yazuki’s blog pointing to this post by Lukas Hartmann, which I’ve sumarised next to Shaheen Pasha’s below.Poor old 23andMe; first the FDA and now Lisa Casey, can they survive? And what would their failure mean for personal genomics?courtesy of Genome.GovOn November […]
At our recent institute symposium I added an additional graphic to try and get people thinking about how much their sequencing costs.Can you work it out: Below are six pairs of circles representing genome, methylome, RNA-seq (GX), ChIP-seq, Exomes and amplicons, size is proportional to […]
We recently had out Institute symposium; lots of talks about the science going on in the building, mostly unpublished work and most of it very exciting. I am always amazed at how lucky I am to be working in a place that uses genomics so […]
Can some explain Myriad’s strategy, other than using bullying tactics to kill competition I don’t get it? Is there any real prospect of the law siding with their point of view? I hope not. And since the US market has some pretty wonderful advertising (surely […]
